Science, Technology, Innovation, Programming, Progress.
patients on the oncological highway — one with the conventional chemotherapy regimen, the other with a new promising immunotherapy. Are the survival curves for these two lanes statistically different? Log-rank tests provide that crucial, objective answer. In SAS, we can use the LIFETEST procedure